9% pay rise for NI civil servants ‘genuine attempt to tackle pay erosion’, says FDA

The FDA is recommending to members to accept the Northern Ireland civil service pay offer for 2024/25, which represents a 9% increase over a 20-month period.
The offer is for a 3% increase from 1st August 2024 to 31st July 2025, and a further 6% increase from 1st August 2025 to 31st March 2026.
Robert Murtagh, FDA National Officer for NI, told BBC News: “We recognise this offer represents a genuine attempt by the Minister for Finance, Dr Caoimhe Archibald, to tackle pay erosion in the NI civil service that has risen over the last decade.
“Civil servants are at the heart of the much-needed transformation to deliver sustainable public services for the people of NI and this pay offer is a step in the right direction.”
Murtagh continued:
“While we are disappointed that the minister was unable to find further funding to increase the 3% pay offer for this year, we appreciate that 6% from August 2025 is a significant improvement and compares favourably to other public sector pay awards across NI and the UK.
“While there is room for improvement, we believe this offer is fair and reasonable and are recommending to our members to accept it.”
Latest news
-
“Significant gaps” in current Northern Ireland standards regime, says Murtagh
FDA National Officer for Northern Ireland Robert Murtagh has called for a strengthened standards regime in Northern Ireland government.
-
Ministers must “step up to the plate” or risk undermining the civil service, says Penman
The FDA has defended the pay and pensions of senior civil servants and called for ministers to do more to defend the civil service.
-
FDA attends Irish Congress of Trade Unions Biennial Delegates Conference in Belfast
Building on the FDA’s increased presence in Northern Ireland (NI), this week the FDA’s National Officer for NI Robert Murtagh has been attending the Irish Congress of Trade Unions Biennial Delegates Conference in Belfast, with General Secretary Dave Penman also in attendance as an observer.